Ketogenic Diet Ameliorates Inflammation by Inhibiting the NLRP3 Inflammasome in Osteoarthritis
Overview
Affiliations
Background: The nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome has been reported to be involved in the pathological process of osteoarthritis (OA) inflammation. Here, we investigated the ketogenic diet (KD), which has been previously demonstrated to inhibit NLRP3 inflammasome activation, to elucidate its protective mechanism against OA in rats.
Methods: Anterior cruciate ligament transaction (ACLT) together with partial medial meniscectomy was used to create a rat knee joint OA model. After treatment with KD or standard diet (SD) for 8 weeks, the knee specimens were obtained for testing.
Results: The KD significantly increased the content of β-hydroxybutyrate (βOHB) in rats. Compared to the SD group, the KD significantly reduced the damage caused by OA in the articular cartilage and subchondral bone. The NLRP3 inflammasome and inflammatory cytokines interleukin-1 β (IL-1β) and IL-18 were significantly increased in the SD group compared with the sham group, while their expression was significantly decreased in rats treated with the KD. In addition, MMP13 was significantly decreased in the KD group compared to that in the SD group, while COL2 was significantly increased.
Conclusions: KD can protect the articular cartilage and subchondral bone in a rat OA model by inhibiting NLRP3 inflammasome activation and reducing the OA inflammatory response.
Dyson G, Barrett M, Schlupp L, Prinz E, Hannebut N, Szymczak A ACR Open Rheumatol. 2025; 7(1):e11794.
PMID: 39853943 PMC: 11760994. DOI: 10.1002/acr2.11794.
β-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in rats.
Kawasaki R, Sakata A, Tatsumi K, Mitani S, Takeda M, Kasuda S Sci Rep. 2024; 14(1):29696.
PMID: 39614095 PMC: 11606947. DOI: 10.1038/s41598-024-77074-6.
Ciaffi J, Mancarella L, Pederzani G, Lisi L, Brusi V, Pignatti F Nutrients. 2024; 16(19).
PMID: 39408203 PMC: 11479182. DOI: 10.3390/nu16193236.
Qu X, Huang L, Rong J Sci Rep. 2024; 14(1):22805.
PMID: 39353986 PMC: 11445255. DOI: 10.1038/s41598-024-73384-x.
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD).
Dynka D, Rodzen L, Rodzen M, Lojko D, Kraszewski S, Ibrahim A J Clin Med. 2024; 13(16).
PMID: 39200999 PMC: 11355934. DOI: 10.3390/jcm13164857.